| (Values in U.S. Thousands) | Dec, 2016 | Sep, 2016 | Jun, 2016 | Mar, 2016 | Dec, 2015 |
| Sales | -9,999,000 | 41,770 | 41,190 | 39,380 | 38,090 |
| Sales Growth | -24,038.23% | +1.41% | +4.60% | +3.39% | +3.09% |
| Net Income | -9,999,000 | 5,440 | 5,400 | -260 | 1,560 |
| Net Income Growth | -183,905.11% | +0.74% | +2,176.93% | -116.67% | -47.47% |
Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Vascular Solutions Inc. manufactures, markets and sells the Vascular Solutions Duett sealing device, which enables cardiologists and radiologists to rapidly seal the puncture site following catheterization procedures such as angiography, angioplasty and stenting. Its product combines a simple balloon catheter delivery mechanism with a powerful, proprietary procoagulant. The company believes its product offers advantages over both manual compression and the three other FDA-approved devices used to seal the puncture site following the catheterization.
Fiscal Year End Date: 12/31